PHASE 2 TRANSCRANIAL PROBE

System, Imaging, Pulsed Doppler, Ultrasonic

BIOSOUND, INC.

The following data is part of a premarket notification filed by Biosound, Inc. with the FDA for Phase 2 Transcranial Probe.

Pre-market Notification Details

Device IDK894163
510k NumberK894163
Device Name:PHASE 2 TRANSCRANIAL PROBE
ClassificationSystem, Imaging, Pulsed Doppler, Ultrasonic
Applicant BIOSOUND, INC. 7990 CASTLEWAY DR. P.O. BOX 50867 Indianapolis,  IN  46250
ContactRobert Courtney
CorrespondentRobert Courtney
BIOSOUND, INC. 7990 CASTLEWAY DR. P.O. BOX 50867 Indianapolis,  IN  46250
Product CodeIYN  
CFR Regulation Number892.1550 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1989-06-14
Decision Date1989-09-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.